Hims & Hers Health Inc [NYSE: HIMS] plunged by -$1.67 during the normal trading session on while it closed the day at $55.48.
Hims & Hers Health Inc stock has also loss -1.51% of its value over the past 7 days. However, HIMS stock has inclined by 67.41% in the 3 months of the year. Over the past six months meanwhile, it has gained 79.72% and gained 129.45% year-on date.
The market cap for HIMS stock reached $12.42 billion, with 215.21 million shares outstanding and 200.60 million shares in the current float. Compared to the average trading volume of 38.08M shares, HIMS reached a trading volume of 26290461 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Hims & Hers Health Inc [HIMS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $47.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 04, 2025. The new note on the price target was released on April 29, 2025, representing the official price target for Hims & Hers Health Inc stock. Previously, the target price had yet another raise from $42 to $60, while Morgan Stanley kept a Equal-Weight rating on HIMS stock. On January 10, 2025, analysts increased their price target for HIMS shares from 24 to 25.
The Average True Range (ATR) for Hims & Hers Health Inc is set at 4.65, with the Price to Sales ratio for HIMS stock in the period of the last 12 months amounting to 6.96. The Price to Book ratio for the last quarter was 22.58, with the Price to Cash per share for the same quarter was set at 1.44. Price to Free Cash Flow for HIMS in the course of the last twelve months was 52.78 with Quick ratio for the last quarter at 1.32.
HIMS stock trade performance evaluation
Hims & Hers Health Inc [HIMS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.51. With this latest performance, HIMS shares dropped by -9.23% in over the last four-week period, additionally plugging by 79.72% over the last 6 months – not to mention a rise of 151.72% in the past year of trading.
#####
Hims & Hers Health Inc [HIMS]: An insightful look at the core fundamentals
Hims & Hers Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.32 and a Current Ratio set at 1.59.
Earnings per share (EPS) analysis for Hims & Hers Health Inc [HIMS] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hims & Hers Health Inc go to 34.58%.
Hims & Hers Health Inc [HIMS]: Institutional Ownership
The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 16.47 million shares, which is approximately 7.6746%. BLACKROCK INC., holding 14.57 million shares of the stock with an approximate value of $$294.25 million in HIMS stocks shares; and BLACKROCK INC., currently with $$121.94 million in HIMS stock with ownership which is approximately 2.814%.
